Business oversight

At Royalty Pharma, we believe that our commitment to maintaining strong governance and robust policy making will create sustainable long-term value for our company, employees, shareholders and other stakeholders.

Managing our business

Risk management, compliance and high ethical standards are foundational to our culture

Our strong corporate governance program, from board oversight to robust management practices, aligns the interests of our stakeholders and underpins our market-leading position.

Board leadership

The Chairman of our Board is our founder, Pablo Legorreta, who has also led the Company as CEO since its inception. Seven of eight directors of our Board are independent, and 100% of our Board committees are comprised of independent directors.

Engaging our shareholders

We communicate with our investors regularly through investor meetings and conferences, management roadshows, press releases, conference calls and through our website.

Corporate Responsibility Committee

We have established a dedicated, cross-functional Corporate Responsibility Committee, comprised of managers and team leads across several departments, that aims to formalize and strengthen our sustainability efforts throughout the business.

Our policies and practices

Robust governance policies and practices

Royalty Pharma’s policies and practices adhere to high standards.

Ethics and compliance
We have clear codes of conduct for our talent and suppliers as well as comprehensive data privacy, cybersecurity, Whistleblower and Human Rights policies.

Promoting transparency
Our Corporate Responsibility Report is aligned with Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB) reporting standards.

Access all of our reports and policies in our Responsibility Resource Center

Our commitment to the environment

Committed to implementing key sustainability practices across our operations

We continue to implement key sustainability practices across our operations and take steps to measure, manage and minimize our environmental impact where possible.

Reducing our operational footprint
We are focused on tracking our carbon footprint, mitigating our impact where we can and identifying ways to reduce our environmental impact.

Our partner network
We look for partners who value environmental sustainability. This is particularly important because we do not conduct biopharmaceutical research and development or manufacture or market biopharmaceutical products.

Sustainability practices - Forest Scene

Stay up to date

Subscribe to Royalty Pharma news and alerts